US markets have seen significant corrections in the last 18 months and 10-15% allocation to US equities in a staggered way can be a prudent diversification, says Ajit Deshmukh, Equirus Wealth MD
'We are talking of a practical solution and not digging our heels in saying 'we don't have to pay you a rupee'
'We have planned a capex of Rs 16,000 crore. Of this, roughly, Rs 4,000 crore is in Europe, with the Netherlands accounting for about Rs 3,000; the balance will be in the UK'
'From 2016 onwards we have become more serious about making films'
'FY24 will be a big year for us. We want to be profitable in all quarters - and for the full financial year'
With the QuEST project, the government realised the importance of quantum technology and decided to turn it into a much bigger programme
While demand has been softening, commodity price deflation, along with cost control measures by corporates, has prevented severe margin contraction, says Mahesh Patil, CIO, Aditya Birla Sun Life AMC
We have been talking to various interested parties, but there is no fixed plan to sell 15 per cent at any point of time, says Umesh Revankar, executive vice chairman of Shriram Finance
'Macroeconomic environment 'significantly uncertain, but varies across industries: Sudhir Singh
'Deloitte will focus on building its advisory business in India'
'This acquisition allows us to complement our business portfolio and growth strategy with the under-penetrated categories'
'Panama may be a small country, but it has long punched above its weight'
'FIFA for us was quite a landmark. It did well on revenue and viewership'
'I have been part of the Nasscom executive council (EC) since 2017'
'Renewables is an affordable way to drive forward electricity generation in India but not even in India is the sun shining or wind blowing everyday'
'Given the small caps' underperformance vis-a-vis large caps last year, they are at a slightly better position valuation wise'
Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar
India remains the most expensive equity market in the region and amongst the most expensive globally, says Ritu Arora, Asia CEO at Allianz Investment Management
Now that we have strength in our balance sheet, we can go for inorganic expansion, too, in markets where we are already present, says Dr Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare
'Anime film series have been a huge success in many parts of the world'